Physicochemical Properties
| Molecular Formula | C36H72NO8P |
| Molecular Weight | 677.93 |
| Exact Mass | 677.499 |
| CAS # | 18194-24-6 |
| Related CAS # | 1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d58;326495-29-8;1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d4;185906-01-8;1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d9;71479-88-4;1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d13;326495-28-7;1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d63;326495-30-1;1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d67;326495-32-3;(Rac)-1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d72;100483-63-4 |
| PubChem CID | 5459377 |
| Appearance | White to off-white solid powder |
| Boiling Point | > 300ºC |
| Melting Point | 130ºC to 139ºC |
| LogP | 8.75 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 36 |
| Heavy Atom Count | 46 |
| Complexity | 765 |
| Defined Atom Stereocenter Count | 1 |
| SMILES | CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC |
| InChi Key | CITHEXJVPOWHKC-UUWRZZSWSA-N |
| InChi Code | InChI=1S/C36H72NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-35(38)42-32-34(33-44-46(40,41)43-31-30-37(3,4)5)45-36(39)29-27-25-23-21-19-17-15-13-11-9-7-2/h34H,6-33H2,1-5H3/t34-/m1/s1 |
| Chemical Name | [(2R)-2,3-di(tetradecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Effect of polyols on the DMPC lipid monolayers and bilayers. Biochim Biophys Acta Biomembr. 2018 Nov;1860(11):2166-2174. |
| Additional Infomation |
1,2-di-O-myristoyl-sn-glycero-3-phosphocholine is a 1,2-diacyl-sn-glycero-3-phosphocholine where the two phosphatidyl acyl groups are specified as tetradecanoyl (myristoyl). It has a role as an antigen and a mouse metabolite. It is a 1,2-diacyl-sn-glycero-3-phosphocholine, a phosphatidylcholine 28:0 and a tetradecanoate ester. Dimyristoyl Lecithin is a myristoylated phosphatidylcholine, and a synthetic phospholipid used in liposomes and lipid bilayers with drug delivery property. A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes. See also: Dimyristoylphosphatidylcholine (annotation moved to). |
Solubility Data
| Solubility (In Vitro) |
Ethanol: 50 mg/mL (73.75 mM) DMSO: < 1 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 5 mg/mL (7.38 mM) (saturation unknown) in 10% EtOH + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear EtOH stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 5 mg/mL (7.38 mM) (saturation unknown) in 10% EtOH + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear EtOH stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 5 mg/mL (7.38 mM) (saturation unknown) in 10% EtOH + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear EtOH stock solution to 900 μL of corn oil and mix well.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.4751 mL | 7.3754 mL | 14.7508 mL | |
| 5 mM | 0.2950 mL | 1.4751 mL | 2.9502 mL | |
| 10 mM | 0.1475 mL | 0.7375 mL | 1.4751 mL |